Abstract:We investigated the effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles. Clinical data of 708 hormone replacement cycles with frozen-thawed blastocyst were retrospectively analyzed. According to quartile (P25) of serum estrogen levels on the endometrium transformation day, the 708 cycles were divided into group A 1 (E2 < 157.5 pg/ml), group A 2 (157.5 pg/ml ≤ E2 < 206.4 pg/ml), group A 3 (206.4 pg/ml ≤ E2 < 302.3 pg/ml) and group A 4 (E2 ≥ 302.3 pg/ml). According to quartile (P25) of serum estrogen levels on the frozen-thawed blastocyst transfer day, the 708 cycles were divided into group B 1 (E2 < 147 pg/ml), group B 2 (147 pg/ml ≤ E2 < 200.4 pg/ml), group B 3 (200.4 pg/ml ≤ E2 < 323 pg/ml) and group B 4 (E2 ≥ 323 pg/ml). According to different clinical outcomes, the 708 cycles were divided into clinical pregnant group and non-clinical pregnant group. The group A 4 (E2 ≥ 302.3 pg/ml on the endometrium transformation day) was significantly lower than other groups in blastocyst implantation rate and multiple-pregnancy rate ( P < 0.05). The days of taking progynova was significantly different among groups on both endometrium transformation day and frozen-thawed blastocyst transfer day ( P < 0.05), but there were no statistical differences in the mean age, endometrial thickness and number of high-quality blastocysts transferred among groups ( P > 0.05). The mean age was significantly younger and the number of high-quality blastocysts transferred was significantly higher in the clinical pregnant group than in the non-clinical pregnant group ( P < 0.05), but endometrial thickness, days of taking progynova, progesterone level on the blastocyst transfer day, and E2 level were not significantly different between both groups ( P > 0.05). Multivariate regression analysis indicated that age was an independent factor affecting clinical pregnancy ( P < 0.05). Correlation analysis displayed that the serum estrogen levels did not affect clinical pregnancy ( P > 0.05). The days of taking progynova and serum estrogen levels before frozen-thawed blastocyst transfer do not affect pregnancy outcomes in hormone replacement cycles.

Estrogen Level Monitoring in Artificial Frozen-Thawed Embryo Transfer Cycles Using Step-Up Regime Without Pituitary Suppression: is It Necessary?

Significance of Serum Estradiol Monitoring in Hormone Replacement-Frozen Embryo Transfer Cycles

Maintenance of early pregnancy without early hormone support after frozen-thawed embryo transfer in hormone replacement treatment cycles.

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

[Application of Femoston in hormone replacement treatment-frozen embryo transfer and its clinical outcomes].

A Clinical Study on the Level of Serum Low Progesterone about Luteal Phase Support for Partial Vaginal Delivery in Assisted Reproductive Technology

Transfer of Fresh Versus Frozen Embryos in Ovulatory Women

Role of monitoring sex hormone in ovarian stimulation cycles

Preparation of the endometrium for frozen embryo transfer: an update on clinical practices

The Relationship Between Serum Oestrogen Levels and Clinical Outcomes of Hormone Replacement Therapy-Frozen Embryo Transfer: a Retrospective Clinical Study.

Impact of Non-GnRH-a Down-regulated Hormone Replacement Therapy and hMG Stimulation as Endometrial Preparation Protocols on Frozen-thawed Embryo Transfer

Effect of estrogen exposure on pregnancy outcomes in artificial frozen-thawed embryo transfer cycles

Route of Administration of Exogenous Progesterone for Luteal Support Does Not Significantly Affect the Serum Concentration in Assisted Reproductive Technology

Effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles

Application of on Non-intramuscular Progesterone in Hormone Replaced Treatment of Frozen-thawed Embryo Transfer

Evaluation of the predictive value for IVF outcomes of serum estrogen level after down regulation

Serum LH Level on the Day of hCG Administration as a Predictor of the Reproductive Outcomes in Ovulation Induction Cycle Frozen-Thawed Embryo Transfer

The effect of elevated progesterone levels before HCG triggering in modified natural cycle frozen-thawed embryo transfer cycles

THE RELATIONSHIP BETWEEN SERUM ESTROGEN (E2) LEVELS AND OUTCOMES OF HORMONE REPLACEMENT THERAPY-FROZEN EMBRYO TRANSFER (HRT-FET).

The influence of progesterone and estradiol level on the day on clinical outcome of frozen thawed embryo transfer in nature cycle.

Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist